Synageva BioPharma Joins National Organization for Rare Disorders, EURORDIS, And The Global Genes Project In Support Of Rare Disease Day 2014

LEXINGTON, Mass.--(BUSINESS WIRE)--Synageva BioPharma Corp. (Synageva) (NASDAQ:GEVA), a biopharmaceutical company developing therapeutic products for rare diseases, joins the National Organization for Rare Disorders (NORD), the European Organisation for Rare Diseases (EURORDIS), The Global Genes Project, and others around the world in observing Rare Disease Day.

Help employers find you! Check out all the jobs and post your resume.